Skip to main content
American heart journal
Percutaneous alternative to the Maze procedure for the treatment of persistent or long-standing persistent atrial fibrillation (aMAZE trial): Rationale and design.
Associations of obesity and body fat distribution with incident atrial fibrillation in the biracial health aging and body composition cohort of older adults.
Galectin-3 and mineralocorticoid receptor antagonist use in patients with chronic heart failure due to left ventricular systolic dysfunction.
Procedure timing as a predictor of inhospital adverse outcomes from implantable cardioverter-defibrillator implantation: insights from the National Cardiovascular Data Registry.
Risk factors associated with the incidence and progression of mitral annulus calcification: the multi-ethnic study of atherosclerosis.
Consideration of patient age and life expectancy in implantable cardioverter-defibrillator referral.
Randomized controlled trial of ventricular elastic support therapy in the treatment of symptomatic heart failure: rationale and design.
The CHADS2 score predicts ischemic stroke in the absence of atrial fibrillation among subjects with coronary heart disease: data from the Heart and Soul Study.
Diastolic dysfunction: improved understanding using emerging imaging techniques.
Prevalence and prognostic significance of incidental cardiac troponin T elevation in ambulatory patients with stable coronary artery disease: data from the Heart and Soul study.
